QR code

Effectiveness and Safety of Low-Sodium Oxybate in Participants with Narcolepsy: Primary Results from the DUET Study

Abstract Introduction A phase 4, prospective, open-label study of low-sodium oxybate (LXB) in narcolepsy (type 1 [NT1] or 2 [NT2]) or idiopathic hypersomnia included novel symptom outcomes important to patients (Jazz DUET; NCT05875974; registered 16 May 2023). Primary results from the narcolepsy coh...

Volledige beschrijving

Bewaard in:
Hoofdauteurs: Logan D. Schneider, Chad M. Ruoff, David T. Plante, Deborah A. Nichols, Teresa L. Steininger, Douglas S. Fuller, M. Todd Kirby, Sarah Akerman, Jessica K. Alexander, Marisa Whalen, Alyssa Cairns
Formaat: Artigo
Taal:Inglês
Gepubliceerd in: Adis, Springer Healthcare 2026-04-01
Reeks:Neurology and Therapy
Onderwerpen:
Low-sodium oxybate
Patient-centric study
Patient-reported outcome
Polysomnography
Sleep architecture
Sleep quality
Online toegang:https://doi.org/10.1007/s40120-026-00921-3
Tags: Voeg label toe
Geen labels, Wees de eerste die dit record labelt!

Gelijkaardige items